Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Lumexa Imaging Holdings, Inc. (LMRI)

11.95 +0.09 (+0.80%)
As of 12:53:04 PM EDT. Market Open.
Trade LMRI on Coinbase
Chart Range Bar
Loading chart for LMRI
  • Previous Close 11.85
  • Open 12.11
  • Bid 8.52 x 100
  • Ask 15.37 x 100
  • Day's Range 11.71 - 12.13
  • 52 Week Range 6.45 - 19.45
  • Volume 133,714
  • Avg. Volume 613,441
  • Market Cap (intraday) 1.148B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.29
  • Earnings Date Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 17.00

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

www.lumexaimaging.com

5,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 8/25/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LMRI
35.43%
S&P 500 (^GSPC)
12.01%

1-Year Return

LMRI
35.95%
S&P 500 (^GSPC)
19.08%

3-Year Return

LMRI
35.95%
S&P 500 (^GSPC)
74.05%

5-Year Return

LMRI
35.95%
S&P 500 (^GSPC)
70.54%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 267.73M
Earnings -28.69M
Profit Margin -10.72%

Q4

FY25

0
100M
200M
-10.7%

Analyst Insights

View More

Analyst Price Targets

9.00 Low
17.00 Average
11.94 Current
23.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 5/20/2026
Analyst Barclays
Rating Action Maintains
Rating Overweight
Price Action Lowers
Price Target 15 -> 9

Statistics

View More

Valuation Measures

Annual
As of 8/24/2026
  • Market Cap

    1.14B

  • Enterprise Value

    2.05B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.09

  • Price/Book (mrq)

    1.85

  • Enterprise Value/Revenue

    1.96

  • Enterprise Value/EBITDA

    15.49

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.66%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.04B

  • Net Income Avi to Common (ttm)

    -27.73M

  • Diluted EPS (ttm)

    -0.29

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    69.7M

  • Total Debt/Equity (mrq)

    158.58%

  • Levered Free Cash Flow (ttm)

    --

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

11.94 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: